awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
1
Q55283747-63FCD492-7C92-4A18-9EFB-304668038E9C
Q55283747-63FCD492-7C92-4A18-9EFB-304668038E9C
BestRank
Statement
http://www.wikidata.org/entity/statement/Q55283747-63FCD492-7C92-4A18-9EFB-304668038E9C
Past, Present, and Future of Rituximab-The World's First Oncology Monoclonal Antibody Therapy.
P2860
Q55283747-63FCD492-7C92-4A18-9EFB-304668038E9C
BestRank
Statement
http://www.wikidata.org/entity/statement/Q55283747-63FCD492-7C92-4A18-9EFB-304668038E9C
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
dadefd7da32918f1d4174f34d5951dfe6e5af2de
P2860
Obinutuzumab (GA101) compared to rituximab significantly enhances cell death and antibody-dependent cytotoxicity and improves overall survival against CD20(+) rituximab-sensitive/-resistant Burkitt lymphoma (BL) and precursor B-acute lymphoblastic l